Mutual exclusivity of hyaluronan and hyaluronidase in invasive group a Streptococcus

Journal of Biological Chemistry

Volumn 289, Issue 46, 2014, Pages 32303-32315

  Henningham, Anna ^a,b   Yamaguchi, Masaya ^a,c   Aziz, Ramy K ^d,e   Kuipers, Kirsten ^a,f   Buffalo, Cosmo Z ^d   Dahesh, Samira ^a   Choudhury, Biswa ^g   Van Vleet, Jeremy ^g   Yamaguchi, Yuka ^a   Seymour, Lisa M ^b   Ben Zakour, Nouri L ^b   He, Lingjun ^h   Smith, Helen V ⁱ   Grimwood, Keith ^j   Beatson, Scott A ^b   Ghosh, Partho ^d   Walker, Mark J ^b   Nizet, Victor ^a,k,l   Colea, Jason N ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CAIRO UNIVERSITY   (Egypt)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g University of California San Diego   (United States)

^h SAN DIEGO STATE UNIVERSITY   (United States)

ⁱ QUEENSLAND HEALTH   (Australia)

^j Queensland Children s Medical Research Institute   (Australia)

^k UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^l RADY CHILDREN'S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOINFORMATICS; GASES; MOLECULAR BIOLOGY;

BIOINFORMATICS ANALYSIS; FULL ENCAPSULATIONS; MOLECULAR GENETICS; MUTUAL EXCLUSIVITIES; PARTIAL ENCAPSULATION; POINT MUTATIONS; REGULATORY PROTEIN; WHOLE GENOME SEQUENCES;

HYALURONIC ACID;

HYALURONIC ACID; HYALURONIDASE; PROTEIN C4BP; REGULATOR PROTEIN; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; COVS PROTEIN, STREPTOCOCCUS PYOGENES; CSRR PROTEIN, STREPTOCOCCUS PYOGENES; ERYTHROGENIC TOXIN; EXOTOXIN; HYALURONATE LYASE; HYALURONOGLUCOSAMINIDASE; POLYSACCHARIDE; POLYSACCHARIDE LYASE; RECOMBINANT PROTEIN; REPRESSOR PROTEIN; ROPB PROTEIN, RHIZOBIUM LEGUMINOSARUM; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLONAL VARIATION; CONTROLLED STUDY; ENCAPSULATION; FEMALE; GENE SEQUENCE; GENOME ANALYSIS; GROUP A STREPTOCOCCAL INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE SPECIES; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; POINT MUTATION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; STREPTOCOCCUS GROUP A; ANIMAL; BIOLOGY; CELL MEMBRANE; ENZYMOLOGY; GENETIC COMPLEMENTATION; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; NEUTROPHIL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; VIRULENCE;

STREPTOCOCCUS SP. 'GROUP A';

ANIMALS; BACTERIAL PROTEINS; BASE SEQUENCE; CELL MEMBRANE; COMPUTATIONAL BIOLOGY; EXOTOXINS; FEMALE; GENETIC COMPLEMENTATION TEST; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NEUTROPHILS; POINT MUTATION; POLYSACCHARIDE-LYASES; POLYSACCHARIDES; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE;

EID: 84911191358     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.602847     Document Type: Article

References (70)

1. Carapetis, J. R., Steer, A. C., Mulholland, E. K., and Weber, M. (2005) The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685-694
2. Facklam, R., Beall, B., Efstratiou, A., Fischetti, V., Johnson, D., Kaplan, E., Kriz, P., Lovgren, M., Martin, D., Schwartz, B., Totolian, A., Bessen, D., Hollingshead, S., Rubin, F., Scott, J., and Tyrrell, G. (1999) emm typing and validation of provisional M types for group A streptococci. Emerg. Infect. Dis. 5, 247-253
3. Courtney, H. S., Liu, S., Dale, J. B., and Hasty, D. L. (1997) Conversion of M serotype 24 of Streptococcus pyogenes to M serotypes 5 and 18: effect on resistance to phagocytosis and adhesion to host cells. Infect. Immun. 65, 2472-2474
4. Steer, A. C., Law, I., Matatolu, L., Beall, B. W., and Carapetis, J. R. (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect. Dis. 9, 611-616
5. Cole, J. N., Barnett, T. C., Nizet, V., and Walker, M. J. (2011) Molecular insight into invasive group A streptococcal disease. Nat. Rev. Microbiol. 9, 724-736
6. Dale, J. B., Washburn, R. G., Marques, M. B., and Wessels, M. R. (1996) Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect. Immun. 64, 1495-1501
7. Foley, M. J., and Wood, W. B., Jr. (1959) Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gel. J. Exp. Med. 110, 617-628
8. Cywes, C., Stamenkovic, I., and Wessels, M. R. (2000) CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J. Clin. Invest. 106, 995-1002
9. Schrager, H. M., Albertí, S., Cywes, C., Dougherty, G. J., and Wessels, M. R. (1998) Hyaluronic acid capsule modulatesMprotein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J. Clin. Invest. 101, 1708-1716
10. Moses, A. E., Wessels, M. R., Zalcman, K., Albertí, S., Natanson-Yaron, S., Menes, T., and Hanski, E. (1997) Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect. Immun. 65, 64-71
11. Wessels, M. R., and Bronze, M. S. (1994) Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc. Natl. Acad. Sci. U. S. A. 91, 12238-12242
12. Wessels, M. R., Goldberg, J. B., Moses, A. E., and DiCesare, T. J. (1994) Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect. Immun. 62, 433-441
13. Wessels, M. R., Moses, A. E., Goldberg, J. B., and DiCesare, T. J. (1991) Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. U. S. A. 88, 8317-8321
14. Ashbaugh, C. D., Moser, T. J., Shearer, M. H., White, G. L., Kennedy, R. C., and Wessels, M. R. (2000) Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol. 2, 283-292
15. Dougherty, B. A., and van de Rijn, I. (1992) Molecular characterization of a locus required for hyaluronic acid capsule production in group A streptococci. J. Exp. Med. 175, 1291-1299
16. Cole, J. N., Aziz, R. K., Kuipers, K., Timmer, A. M., Nizet, V., and van Sorge, N. M. (2012) A conserved UDP-glucose dehydrogenase encoded outside the hasABC operon contributes to capsule biogenesis in group A Streptococcus. J. Bacteriol. 194, 6154-6161
17. DeAngelis, P. L., Papaconstantinou, J., and Weigel, P. H. (1993) Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. J. Biol. Chem. 268, 19181-19184
18. Ravins, M., Jaffe, J., Hanski, E., Shetzigovski, I., Natanson-Yaron, S., and Moses, A. E. (2000) Characterization of a mouse-passaged, highly encapsulated variant of group A Streptococcus in in vitro and in vivo studies. J. Infect. Dis. 182, 1702-1711
19. Stollerman, G. H., and Dale, J. B. (2008) The importance of the group A Streptococcus capsule in the pathogenesis of human infections: a historical perspective. Clin. Infect. Dis. 46, 1038-1045
20. Sumby, P., Porcella, S. F., Madrigal, A. G., Barbian, K. D., Virtaneva, K., Ricklefs, S. M., Sturdevant, D. E., Graham, M. R., Vuopio-Varkila, J., Hoe, N. P., and Musser, J. M. (2005) Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J. Infect. Dis. 192, 771-782
21. Sumby, P., Whitney, A. R., Graviss, E. A., DeLeo, F. R., and Musser, J. M. (2006) Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2, e5
22. Walker, M. J., Hollands, A., Sanderson-Smith, M. L., Cole, J. N., Kirk, J. K., Henningham, A., McArthur, J. D., Dinkla, K., Aziz, R. K., Kansal, R. G., Simpson, A. J., Buchanan, J. T., Chhatwal, G. S., Kotb, M., and Nizet, V. (2007) DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat. Med. 13, 981-985
23. Cole, J. N., McArthur, J. D., McKay, F. C., Sanderson-Smith, M. L., Cork, A. J., Ranson, M., Rohde, M., Itzek, A., Sun, H., Ginsburg, D., Kotb, M., Nizet, V., Chhatwal, G. S., and Walker, M. J. (2006) Trigger for group A streptococcal M1T1 invasive disease. FASEB J. 20, 1745-1747
24. Ponting, C. P., Marshall, J. M., and Cederholm-Williams, S. A. (1992) Plasminogen: a structural review. Blood Coagul. Fibrinolysis 3, 605-614
25. Marcum, J. A., and Kline, D. L. (1983) Species specificity of streptokinase. Comp. Biochem. Physiol. B 75, 389-394
26. Pancholi, V., and Fischetti, V. A. (1998) α-Enolase, a novel strong plasmin-(ogen) binding protein on the surface of pathogenic streptococci. J. Biol. Chem. 273, 14503-14515
27. Pancholi, V., and Fischetti, V. A. (1992) A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate dehydrogenase with multiple binding activity. J. Exp. Med. 176, 415-426
28. Berge, A., and Sjöbring, U. (1993) PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J. Biol. Chem. 268, 25417-25424
29. Sanderson-Smith, M. L., Dowton, M., Ranson, M., and Walker, M. J. (2007) The plasminogen-binding group A streptococcal M protein-related protein Prp binds plasminogen via arginine and histidine residues. J. Bacteriol. 189, 1435-1440
30. Wang, H., Lottenberg, R., and Boyle, M. D. (1995) Analysis of the interaction of group A streptococci with fibrinogen, streptokinase, and plasminogen. Microb. Pathog. 18, 153-166
31. Coleman, J. L., and Benach, J. L. (1999) Use of the plasminogen activation system by microorganisms. J. Lab. Clin. Med. 134, 567-576
32. Beres, S. B., Richter, E. W., Nagiec, M. J., Sumby, P., Porcella, S. F., DeLeo, F. R., and Musser, J. M. (2006) Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 103, 7059-7064
33. Flores, A. R., Jewell, B. E., Fittipaldi, N., Beres, S. B., and Musser, J. M. (2012) Human disease isolates of serotype M4 and M22 group A Streptococcus lack genes required for hyaluronic acid capsule biosynthesis. mBio 3, e00413-e00412
34. Whitehead, B. D., Smith, H. V., and Nourse, C. (2011) Invasive group A streptococcal disease in children in Queensland. Epidemiol. Infect. 139, 623-628
35. Hynes, W. L., Dixon, A. R., Walton, S. L., and Aridgides, L. J. (2000) The extracellular hyaluronidase gene (hylA) of Streptococcus pyogenes. FEMS Microbiol. Lett. 184, 109-112
36. Kansal, R. G., McGeer, A., Low, D. E., Norrby-Teglund, A., and Kotb, M. (2000) Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect. Immun. 68, 6362-6369
37. Hollands, A., Pence, M. A., Timmer, A. M., Osvath, S. R., Turnbull, L., Whitchurch, C. B., Walker, M. J., and Nizet, V. (2010) Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A Streptococcus M1T1 clone. J. Infect. Dis. 202, 11-19
38. Bessen, D. E., and Kalia, A. (2002) Genomic localization of a T serotype locus to a recombinatorial zone encoding extracellular matrix-binding proteins in Streptococcus pyogenes. Infect. Immun. 70, 1159-1167
39. Ramachandran, V., McArthur, J. D., Behm, C. E., Gutzeit, C., Dowton, M., Fagan, P. K., Towers, R., Currie, B., Sriprakash, K. S., and Walker, M. J. (2004) Two distinct genotypes of prtF2, encoding a fibronectin binding protein, and evolution of the gene family in Streptococcus pyogenes. J. Bacteriol. 186, 7601-7609
40. Maamary, P. G., Ben Zakour, N. L., Cole, J. N., Hollands, A., Aziz, R. K., Barnett, T. C., Cork, A. J., Henningham, A., Sanderson-Smith, M., McArthur, J. D., Venturini, C., Gillen, C. M., Kirk, J. K., Johnson, D. R., Taylor, W. L., Kaplan, E. L., Kotb, M., Nizet, V., Beatson, S. A., and Walker, M. J. (2012) Tracing the evolutionary history of the pandemic group A streptococcal M1T1 clone. FASEB J. 26, 4675-4684
41. Cole, J. N., Pence, M. A., von Köckritz-Blickwede, M., Hollands, A., Gallo, R. L., Walker, M. J., and Nizet, V. (2010) M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. mBio 1, e00191-e00110
42. Pence, M. A., Rooijakkers, S. H., Cogen, A. L., Cole, J. N., Hollands, A., Gallo, R. L., and Nizet, V. (2010) Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A Streptococcus. J. Innate Immun. 2, 587-595
43. Hollands, A., Aziz, R. K., Kansal, R., Kotb, M., Nizet, V., and Walker, M. J. (2008) A naturally occurring mutation in ropB suppresses SpeB expression and reduces M1T1 group A streptococcal systemic virulence. PLoS One 3, e4102
44. Guo, X., Shi, Y., Sheng, J., and Wang, F. (2014) A novel hyaluronidase produced by Bacillus sp. A50. PLoS One 9, e94156
45. Lin, B., Hollingshead, S. K., Coligan, J. E., Egan, M. L., Baker, J. R., and Pritchard, D. G. (1994) Cloning and expression of the gene for group B streptococcal hyaluronate lyase. J. Biol. Chem. 269, 30113-30116
46. Baker, J. R., Dong, S., and Pritchard, D. G. (2002) The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A. Biochem. J. 365, 317-322
47. Dahesh, S., Nizet, V., and Cole, J. N. (2012) Study of streptococcal hemoprotein receptor (Shr) in iron acquisition and virulence of M1T1 group A Streptococcus. Virulence 3, 566-575
48. Blom, A. M., Berggârd, K., Webb, J. H., Lindahl, G., Villoutreix, B. O., and Dahlbäck, B. (2000) Human C4b-binding protein has overlapping, but not identical, binding sites for C4b and streptococcalMproteins. J. Immunol. 164, 5328-5336
49. Ferretti, J. J., McShan, W. M., Ajdic, D., Savic, D. J., Savic, G., Lyon, K., Primeaux, C., Sezate, S., Suvorov, A. N., Kenton, S., Lai, H. S., Lin, S. P., Qian, Y., Jia, H. G., Najar, F. Z., Ren, Q., Zhu, H., Song, L., White, J., Yuan, X., Clifton, S. W., Roe, B. A., and McLaughlin, R. (2001) Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. U. S. A. 98, 4658-4663
50. Ikebe, T., Ato, M., Matsumura, T., Hasegawa, H., Sata, T., Kobayashi, K., and Watanabe, H. (2010) Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates. PLoS Pathog. 6, e1000832
51. Hynes, W., Johnson, C., and Stokes, M. (2009) A single nucleotide mutation results in loss of enzymatic activity in the hyaluronate lyase gene of Streptococcus pyogenes. Microb. Pathog. 47, 308-313
52. Hair, P. S., Wagner, S. M., Friederich, P. T., Drake, R. R., Nyalwidhe, J. O., and Cunnion, K. M. (2012) Complement regulator C4BP binds to Staphylococcus aureus and decreases opsonization. Mol. Immunol. 50, 253-261
53. Agarwal, V., Hammerschmidt, S., Malm, S., Bergmann, S., Riesbeck, K., and Blom, A. M. (2012) Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion. J. Immunol. 189, 3575-3584
54. Margarit, I., Bonacci, S., Pietrocola, G., Rindi, S., Ghezzo, C., Bombaci, M., Nardi-Dei, V., Grifantini, R., Speziale, P., and Grandi, G. (2009) Capturing host-pathogen interactions by protein microarrays: identification of novel streptococcal proteins binding to human fibronectin, fibrinogen, and C4BP. FASEB J. 23, 3100-3112
55. Blom, A. M., and Ram, S. (2008) Contribution of interactions between complement inhibitor C4b-binding protein and pathogens to their ability to establish infection with particular emphasis on Neisseria gonorrhoeae. Vaccine 26, I49-I55
56. Jenkins, H. T., Mark, L., Ball, G., Persson, J., Lindahl, G., Uhrin, D., Blom, A. M., and Barlow, P. N. (2006) Human C4b-binding protein, structural basis for interaction with streptococcalMprotein, a major bacterial virulence factor. J. Biol. Chem. 281, 3690-3697
57. Carlsson, F., Berggård, K., Stålhammar-Carlemalm, M., and Lindahl, G. (2003) Evasion of phagocytosis through cooperation between two ligandbinding regions in Streptococcus pyogenes M protein. J. Exp. Med. 198, 1057-1068
58. Persson, J., Beall, B., Linse, S., and Lindahl, G. (2006) Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein. PLoS Pathog. 2, e47
59. Mosesson, M. W. (2005) Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 3, 1894-1904
60. Horstmann, R. D., Sievertsen, H. J., Leippe, M., and Fischetti, V. A. (1992) Role of fibrinogen in complement inhibition by streptococcal M protein. Infect. Immun. 60, 5036-5041
61. Carlsson, F., Sandin, C., and Lindahl, G. (2005) Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol. Microbiol. 56, 28-39
62. Macheboeuf, P., Buffalo, C., Fu, C. Y., Zinkernagel, A. S., Cole, J. N., Johnson, J. E., Nizet, V., and Ghosh, P. (2011) Streptococcal M1 protein constructs a pathological host fibrinogen network. Nature 472, 64-68
63. Lithgow, A., Duke, T., Steer, A., and Smeesters, P. R. (2014) Severe group A streptococcal infections in a paediatric intensive care unit. J. Paediatr. Child Health 50, 687-692
64. Oliver, M. A., Rojo, J. M., Rodríguez de Córdoba, S., and Alberti, S. (2008) Binding of complement regulatory proteins to group A Streptococcus. Vaccine 26, I75-I78
65. Maclennan, A. P. (1956) The production of capsules, hyaluronic acid and hyaluronidase by group A and group C streptococci. J. Gen. Microbiol. 14, 134-142
66. Faber, V., and Rosendal, K. (1954) Streptococcal hyaluronidase. II. Studies on the production of hyaluronidase and hyaluronic acid by representatives of all types of hemolytic streptococci belonging to group A. Acta Pathol. Microbiol. Scand 35, 159-164
67. Maclennan, A. P. (1956) The production of capsules, hyaluronic acid and hyaluronidase by 25 strains of group C streptococci. J. Gen. Microbiol. 15, 485-491
68. Creti, R., Imperi, M., Pataracchia, M., Alfarone, G., Recchia, S., and Baldassarri, L. (2012) Identification and molecular characterization of a S. agalactiae strain lacking the capsular locus. Eur. J. Clin. Microbiol. Infect. Dis. 31, 233-235
69. Caldeira, N. G., de Filippis, I., Arruda, T. C., Real, M. E., de Jesus, A. B., and de Almeida, A. E. (2013) Haemophilus influenzae serotype b and a capsuledeficient type mutant (b-) invasive disease in a partially vaccinated child in Brazil. J. Med. Microbiol. 62, 655-657
70. Hoang, L. M., Thomas, E., Tyler, S., Pollard, A. J., Stephens, G., Gustafson, L., McNabb, A., Pocock, I., Tsang, R., and Tan, R. (2005) Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus. Clin. Infect. Dis. 40, e38-e42